General Oncology is a clinical-stage biopharmaceutical company developing medicines for metastatic cancers. GO-4, our lead investigational drug, employs a first-in-class mechanism to target DNA repair in cancer cells. In an ongoing Phase 1 trial, it has demonstrated a promising signal of efficacy in stage IV pancreatic adenocarcinoma, with 8 of 12 patients surviving beyond 19 months. One patient remains free of disease at 54 months; another at 37 months.

See the CURE interview about our trial.

We are actively raising our Series A and are hiring a VP of Capital Markets and Investor Relations to lead that effort.

This is a sales role. You will be on the road, on the phone, and in rooms with institutional investors, family offices, and high-net-worth individuals. You will own the outreach, build the pipeline, and close the round. If you are energized by the hunt, by the pitch, by turning a cold call into a committed check — this role was built for you.

What you'll do:
• Drive outreach to institutional investors, family offices, and other capital sources.
• Develop and deliver the equity story across formats — meetings, decks, memos, calls.
• Manage investor pipeline and communications through close.
• Translate complex clinical and financial data into compelling investor narratives.

What we're looking for:
• Demonstrated experience raising capital — not managing it, raising it.
• Comfort in early conversations with skeptical, sophisticated investors.
• Exceptional written and verbal communication skills.
• The kind of person who follows up without being asked.

Compensation: $200,000–$300,000 base salary, plus bonus and equity.

Location: On-site, Newton, Massachusetts.